Category: basic life sciences retractions

Caught Our Notice: Oops — paper included proofreader’s query

Via Wikimedia

Title: Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases

What Caught Our Attention: Everyone makes mistakes — but some are more amusing than others. In one recent correction, the publisher (Wiley) admitted to including a proofreader’s query in the published manuscript. But didn’t say what the query was.

We looked around, and think we found the added notes in the abstract on the PubMed entry (emphasis ours):  Continue reading Caught Our Notice: Oops — paper included proofreader’s query

Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Via Wikimedia

Title: Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis

What Caught Our Attention: A big peer review (and perhaps academic mentorship) fail.  These researchers used the wrong anticoagulant for their blood samples, leading them to believe that certain blood components were fighting microbes. The authors counted the number of colonies to show how well or poorly Tuberculin mycobacteria were growing in cultures — but blood samples need anticoagulants to prevent clots before analysis, and they used an anticoagulant that actually prevented the microbes from colonizing. The authors (and reviewers) should have known this from  Continue reading Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

A journal retracted a paper when authors couldn’t pay. Then it retracted the retraction.

Oops.

A plant journal recently retracted a 2017 paper, saying the authors couldn’t pay the page charges ($110/page). The notice has since disappeared, and the journal announced on Twitter Thursday it was issued in error. The paper is now intact on the journal’s site.

This isn’t the first time the journal has withdrawn a statement that authors couldn’t pay the page charges — we’ve discovered the journal removed a line to that effect from a 2015 retraction notice (although in that case, it left the retraction intact). Page charges, often required by traditional publishers, typically cover printing costs; they differ from article processing charges (APCs) levied by open-access journals, which cover the cost of publishing the paper and making it freely available.

We’ve contacted editors at the journal and its publisher, Taylor & Francis, to try to find out why there are mixed messages about author page charges. A spokesperson for the publisher said it was unable to respond before deadline, but it was looking into the matter:

I can confirm that we are committed to following [Committee on Publication Ethics] guidelines and that we are taking this issue seriously.

In the meantime, here’s what we know.

Continue reading A journal retracted a paper when authors couldn’t pay. Then it retracted the retraction.

Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Carlo Croce

Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction.

In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging that the paper’s corresponding author, Stefan Costinean, published data without their knowledge or permission and without “accurately acknowledging their contributions to the research.” Although the PLOS ONE paper mentioned Croce’s and Garzon’s contributions in the acknowledgements section, the two were not included as co-authors. We have obtained a copy of the report describing OSU’s preliminary probe; it did not find evidence of misconduct, but recommended the paper be retracted for using data without permission. Although Costinean disagreed, the journal has since retracted the paper.

Croce has been on the other side of this process: Seven of his papers have been retracted for issues including manipulation and duplication. After a New York Times article, published in March, explored misconduct allegations against Croce, OSU said the university is “instituting an independent external review.” Croce is currently suing the New York Times, alleging that the newspaper defamed him in the story.

Continue reading Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Researchers ask to retract cancer paper five days after it’s flagged by journal

Researchers from the University of Kansas asked to retract their paper only days after the journal issued an expression of concern related to some of the images.

The retraction notice marks the close of an episode that started in June, but it doesn’t provide much closure: Figures in the paper apparently do not match primary data, but there’s no hint as to how that happened.

In a statement sent to JCS — just five days after the expression of concern came out — last author Kristi Neufeld, a cancer biologist at KU, wrote: Continue reading Researchers ask to retract cancer paper five days after it’s flagged by journal

More duplications for researcher accused of misconduct in lawsuit

Despite losing a lawsuit against his former mentor, a researcher hasn’t stopped his efforts to discredit his mentor’s work. These efforts have led to new editorial notices — including, most recently, a correction and expression of concern for one paper by a former colleague, who wasn’t even the subject of the lawsuit.

In the 2014 suit, former Brown University postdoc Andrew Mallon said research misconduct by John Marshall — his lab director and former business partner– tainted a 2013 paper published in PLoS Biology. Though the case failed to trigger the retraction Mallon sought, it put his concerns into the public record; the text of the lawsuit includes an accusation of misconduct against Cong Cao — Marshall’s former mentee and the first author of that 2013 paper.

Mallon has since contacted journals to raise concerns about papers by Cao, and two journals have taken action. The most recent move: On Aug. 10, the Biochemical Journal did something we don’t see very often — it issued both a correction and an expression of concern (EoC) for one of Cao’s papers: “EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration,” originally published Nov. 14, 2006. Continue reading More duplications for researcher accused of misconduct in lawsuit

Caught Our Notice: Concerns about image in 2008 paper prompt editorial notice

Via Wikimedia

Title: Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma

What caught our attention: One year ago, a PubPeer user suggested an image from a 2008 paper looked similar to one from another paper. After the authors stated their belief in the soundness of the image, without providing the originals, the journal issued only an Expression of Concern for the paper. Some journals have issued retractions for lack of original data, some have issued corrections, and even fewer have published editorial notices. Expressions of concern usually indicate that some type of final resolution will be announced, but in reality, a significant proportion remain unresolved for years. Based on the wording of this notice, it may be around for a while. Continue reading Caught Our Notice: Concerns about image in 2008 paper prompt editorial notice

Widely used U.S. government database delists cancer journal

The U.S. government biomedical research database MEDLINE no longer includes a cancer journal with a storied past.

Starting August 2017, researchers looking up journals indexed in MEDLINE (which is accessed via PubMed) could no longer find new articles published by Oncotarget, once included on the now-defunct list of possibly predatory journals compiled by librarian Jeffrey Beall.

Joyce Backus, the National Library of Medicine’s Associate Director for Library Operations, declined to say why Oncotarget had been deselected from MEDLINE:

Continue reading Widely used U.S. government database delists cancer journal

Unnamed institution makes baffling retraction requests, journals comply

Two journals are retracting papers published by researchers affiliated with Children’s Hospital Los Angeles (CHLA).

To be frank, we’re baffled by most of this story. The retraction notices say “the institution” requested the retractions, but don’t name it; the first and last authors are also affiliated with the University of Southern California, as well as CHLA. Neither journal will say which institution sent the request, and USC and CHLA have each declined to comment on the retractions.

Here’s what we do know: Continue reading Unnamed institution makes baffling retraction requests, journals comply

Caught Our Notice: An “absolutely perfect retraction”

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, more than 1300 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at [email protected].

Title: Skeletal muscle-specific CPT1 deficiency elevates lipotoxic intermediates but preserves insulin sensitivity

What caught our attention:  Continue reading Caught Our Notice: An “absolutely perfect retraction”